image
image
24 April, 2020

Will You Be Counted In The Census?

icon
[caption id="attachment_2319" align="aligncenter" width="1200"] Image: Lumen5[/caption] How can marginalized groups be inspired to take part in the census during a pandemic? Sharvin Lee with Michigan Voices is experimenting with difference approaches. She created a short video that appeals to different races, ages and religions. Its call to action is simple: take a pledge to be counted. Sharvin created this video in less than an hour on her laptop, with a little help from DemLabs using the free Lumen5 app. Create your own video for free with just a laptop Lumen5 is a wonderful, free app that's ideal for campaigns and groups of all sizes. Benefits: 1. The app is free. 2. Easy to learn and use. 3. A large royalty-free library of hundreds of images and video clips is included. 4. App includes royalty-free soundtracks. 5. Upload your own images, videos and soundtracks to create a video. 6. Build your video in small segments that can be previewed independently. 7. It's easy to add captions. 8. Choice of templates for Facebook, Instagram and Snapchat. 9. Videos can be previewed and edited before being published. 10. The videos created can be exported from Lumen5 and shared freely. https://youtu.be/LjrgegLL68A DemCast Learn how to use Lumen5 at a free training course that DemLabs and Demcast produced. "It is incredibly hard for blue stories to get out and connect with Americans who need to believe they can make a difference in 2020. The left needs its own platform for curating on-point content and grassroots messaging, driving engagement and combating negative misinformation campaigns and bots on the right. DemCast is mission-driven non-profit, that aims to help Democrats pick up seats across the country at every level of government. It collects the best content from grassroots groups, activists and volunteers in a single location. DemCast trains an army of social media accounts to share  DemCast site content, and also flag/share other pro-blue stories and posts floating around social media using a unique set of DemCast hashtags." Take away The battle for mindshare in a pandemic is online. Innovative apps, more trained volunteers and broad online distribution make a huge difference. Learn more here. Deepak Co-Founder, DemLabs Please share this blogDemLabs is a SF-based, progressive hub for ongoing technology and creative innovation with free and affordable apps. Donate here to support our work.

Subscribe to DemLabs Bulletin

case study image
20 Jun’ 2024

The moment you realize Affordable Healthcare really is a life or death issue

Your life and health is worth more than the MAGA agenda. "President Biden is fighting for families who are struggling with health care costs and pharmaceutical...

case study image
19 Jun’ 2024

President Biden’s Action To Protect Undocumented Spouses: Mapping the impact

President Biden announces new policy shielding undocumented spouses of U.S. citizens from deportation. - NBC The new policy is one of the most significant actions to...

case study image
15 Jun’ 2024

Don’t Become A MAGA Handmaid In The Republican War On Women

Raped by a man in position of power, Handmaids have no access to an abortion. The Handmaid's Tale is a fictional story about Gilead a Christian...

case study image
14 Jun’ 2024

MAGA Justices ban abortions but approve machine guns? We map the potential carnage.

"Supreme Court just effectively legalized machine guns" "MAGA Justices on the Supreme Court approve bump stocks that allow semiautomatic rifles to fire hundreds of bullets a...

case study image
9 Jun’ 2024

Amplify your message with a shared set of talking points

The same message heard several times is more persuasive. How do you get your extended team of volunteers, canvassers, staff and candidates to stick to the...

case study image
9 Jun’ 2024

Asthma Relief: President Biden Lowers Inhaler Costs to $35/month

Drugmakers to cap cost of asthma inhalers at $35 per month "New out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer...